Thanks.
So is the 10/12 result (just announced yesterday) part of the formal trail or simply an pre-play?
We can imaging US is now urgently need some really efficient treatment to curb the death rate sooner than later, it's logical to think this trail can be concluded less than 4 months ( they may not need it 4 months later when the death rate could be near zero...), so I tend to agree with you @aquazul the trail could end anytime when adequate numbers are obtained.
The market, particularly US market has a much stronger expectation that in Aussie and will take the lead for any share price indication, even though this is an ASX company
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-496
-
- There are more pages in this discussion • 352 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |